Peipei Ping, Ph.D., FAHA
Professor of Physiology and Medicine

e-mail:
pping@mednet.ucla.edu

peipei ping ucla

peipei ping ucla

peipei ping ucla

peipei ping ucla

peipei ping ucla

peipei ping ucla

peipei ping ucla

Introduction:

Peipei Ping is Professor of Physiology and Medicine at the University of California at Los Angeles (UCLA), School of Medicine. Born in Beijing, China, she graduated from Zhejiang University in 1985 with double majors in Medicine and Bioengineering. Dr. Ping received her graduate training in cardiovascular physiology and pathology under the mentorship of Dr. Paul C Johnson at the University of Arizona. Her postdoctoral training was with Dr. James Faber at the University of North Carolina (UNC) Chapel Hill, and later with Dr. Kirk Hammond in the Molecular Cardiology Training Program (Directed by Dr. James Covell) at the University of California at San Diego (UCSD). She was promoted to Assistant Adjunct Professor at UCSD in 1995. Subsequently, she was appointed as Assistant Professor of Physiology and Medicine at the University of Louisville in 1996, and advanced to Associate Professor in 2000. In 2002, Dr. Ping was recruited by UCLA School of Medicine as Professor of Physiology and Medicine, and Director of the Proteomic Laboratory at the Cardiovascular Research Laboratories.

Dr. Peipei Ping has served on the Editorial Boards of American Journal of Physiology, Circulation Research, Journal of Molecular and Cellular Cardiology, Circulation, Proteomics, and Journal of Proteome Research. She is Fellow of the American Physiological Society (APS), Cardiovascular Section (2001-current), and Fellow of American Heart Association (FAHA) (1998-current). She has served on the APS Award Committee; on the AHA Basic Science Council Program Committee; She also serves on the council of International Society of Heart Research (ISHR, 2006-2012); on the Environmental Protective Agency (EPA) Board of Scientific Review (2005-2007); and on the Sarnoff Cardiology Scientific Advisory Committee.

Dr. Peipei Ping has also a devoted service record at NIH; she served on the NIH CSR CVA study section, and on the study section of Myocardial Ischemia and Metabolism (MIM) as a member and Chairperson (2003-2006). In 2002, she was appointed to the first NHLBI Director’s Clinical Proteomic Working Group; subsequently, she served as the chair of the NHLBI evaluation committee on Clinical Proteomic Centers (2005), and was instrumental in establishing the NHLBI Clinical Proteomic Centers. She continuous to play a leadership role in the External Advisory Panel for these NHLBI Clinical Proteomic Programs (2004-current). She has recently been appointed as Chairperson of NHLBI working group on the role of mitochondria in cardiovascular diseases (2007-2008).

Dr. Peipei Ping is actively involved with the Human Proteome Organization (HUPO). She was recruited by Sam Hanash as one of the 17 founding council members; she has served on the HUPO Council (2001-current) and Executive Committee. She was elected as Co-Leader of the Cell Model Proteome Initiative (2002); as co chairs of the Cardiovascular Proteomic Initiative (2006-2007); as Chair of Education Committee (2003-2004) of HPPP; as an EC member of Human Plasma Proteome Initiative (2002-current as Chair of HUPO Award Committee (2003-2007); as Co-Chair of Scientific Program Committee (2004, 2006, 2009); and as Chair of HUPO Publications Committee (2005-2008). She has successfully led a committee effort in establishing official journals for HUPO. Dr. Ping served as the Secretary General of US-HUPO (2003-2005) under the Presidency of Catherine Fenselau; and is currently the Secretary General of International-HUPO (2007-2008) under the Presidency of Rolf Apweiler.